lobbying_activities: 2684157
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2684157 | 4094bd0e-dbac-41bb-be1e-29eea35ef496 | Q3 | MEHLMAN CONSULTING, INC. | 284950 | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | 2021 | third_quarter | CPT | The Stalling Act. The Affordable Prescriptions for Patients through promoting Competition Act of 2021. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 110000 | 0 | 0 | 2021-10-18T10:33:53.350000-04:00 |